{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T00:35:33Z","timestamp":1717720533074},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,6]]},"DOI":"10.7759\/cureus.61831","type":"journal-article","created":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T18:00:26Z","timestamp":1717696826000},"source":"Crossref","is-referenced-by-count":0,"title":["Fibrillary Glomerulonephritis Leading to End-Stage Renal Disease in the Absence of Active or Chronic Hepatitis C Infection: Current Insights"],"prefix":"10.7759","author":[{"given":"Maryam","family":"Saleem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maahin M","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassaan","family":"Iftikhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00853.x","article-title":"Fibrillary and immunotactoid glomerulonephritis: distinct entities with different clinical and pathologic features","volume":"63","author":"Rosenstock JL","year":"2003","unstructured":"Rosenstock JL, Markowitz GS, Valeri AM, Sacchi G, Appel GB, D'Agati VD. Fibrillary and immunotactoid glomerulonephritis: distinct entities with different clinical and pathologic features. Kidney Int. 2003, 63:1450-61. 10.1046\/j.1523-1755.2003.00853.x","journal-title":"Kidney Int"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2019.03.021","article-title":"New developments in the diagnosis of fibrillary glomerulonephritis","volume":"96","author":"Nasr SH","year":"2019","unstructured":"Nasr SH, Fogo AB. New developments in the diagnosis of fibrillary glomerulonephritis. Kidney Int. 2019, 96:581-92. 10.1016\/j.kint.2019.03.021","journal-title":"Kidney Int"},{"key":"ref3","article-title":"Rapidly progressive glomerulonephritis associated with hepatitis C virus infection","volume":"49","author":"Usalan C","year":"1998","unstructured":"Usalan C, Erdem Y, Altun B, Nar A, Yasavul U, Turgan C, Ca\u011flar S. Rapidly progressive glomerulonephritis associated with hepatitis C virus infection. Clin Nephrol. 1998, 49:129-31.","journal-title":"Clin Nephrol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V9122244","article-title":"Hepatitis C viral infection is associated with fibrillary glomerulonephritis and immunotactoid glomerulopathy","volume":"9","author":"Markowitz GS","year":"1998","unstructured":"Markowitz GS, Cheng JT, Colvin RB, Trebbin WM, D'Agati VD. Hepatitis C viral infection is associated with fibrillary glomerulonephritis and immunotactoid glomerulopathy. J Am Soc Nephrol. 1998, 9:2244-52. 10.1681\/ASN.V9122244","journal-title":"J Am Soc Nephrol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2019.00020","article-title":"HCV-associated nephropathies in the era of direct acting antiviral agents","volume":"6","author":"Angeletti A","year":"2019","unstructured":"Angeletti A, Cantarelli C, Cravedi P. HCV-associated nephropathies in the era of direct acting antiviral agents. Front Med (Lausanne). 2019, 6:20. 10.3389\/fmed.2019.00020","journal-title":"Front Med (Lausanne)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.08300910","article-title":"Fibrillary glomerulonephritis: a report of 66 cases from a single institution","volume":"6","author":"Nasr SH","year":"2011","unstructured":"Nasr SH, Valeri AM, Cornell LD, Fidler ME, Sethi S, Leung N, Fervenza FC. Fibrillary glomerulonephritis: a report of 66 cases from a single institution. Clin J Am Soc Nephrol. 2011, 6:775-84. 10.2215\/CJN.08300910","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2019.04.013","article-title":"Fibrillary glomerulonephritis: an update","volume":"4","author":"Rosenstock JL","year":"2019","unstructured":"Rosenstock JL, Markowitz GS. Fibrillary glomerulonephritis: an update. Kidney Int Rep. 2019, 4:917-22. 10.1016\/j.ekir.2019.04.013","journal-title":"Kidney Int Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2022.09.020","article-title":"Subclass changes in fibrillary glomerulonephritis","volume":"8","author":"Biederman LE","year":"2023","unstructured":"Biederman LE, Ibrahim D, Satoskar AA, Nadasdy T, Brodsky SV. Subclass changes in fibrillary glomerulonephritis. Kidney Int Rep. 2023, 8:202-5. 10.1016\/j.ekir.2022.09.020","journal-title":"Kidney Int Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1159\/000525542","article-title":"Fibrillary glomerulonephritis, DNAJB9, and the unfolded protein response","volume":"2","author":"Andeen NK","year":"2022","unstructured":"Andeen NK, Kung VL, Robertson J, Gurley SB, Avasare RS, Sitaraman S. Fibrillary glomerulonephritis, DNAJB9, and the unfolded protein response. Glomerular Dis. 2022, 2:164-75. 10.1159\/000525542","journal-title":"Glomerular Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.34067\/KID.0002532020","article-title":"Fibrillary glomerulonephritis and DnaJ homolog subfamily B member 9 (DNAJB9)","volume":"1","author":"Klomjit N","year":"2020","unstructured":"Klomjit N, Alexander MP, Zand L. Fibrillary glomerulonephritis and DnaJ homolog subfamily B member 9 (DNAJB9). Kidney360. 2020, 1:1002-13. 10.34067\/KID.0002532020","journal-title":"Kidney360"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.03870319","article-title":"Fibrillary glomerulonephritis: clinicopathologic features and atypical cases from a multi-institutional cohort","volume":"14","author":"Andeen NK","year":"2019","unstructured":"Andeen NK, Troxell ML, Riazy M, et al.. Fibrillary glomerulonephritis: clinicopathologic features and atypical cases from a multi-institutional cohort. Clin J Am Soc Nephrol. 2019, 14:1741-50. 10.2215\/CJN.03870319","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2007.05.027","article-title":"Rituximab treatment of dysproteinemias affecting the kidney: a review of three cases","volume":"50","author":"Bhat P","year":"2007","unstructured":"Bhat P, Weiss S, Appel GB, Radhakrishnan J. Rituximab treatment of dysproteinemias affecting the kidney: a review of three cases. Am J Kidney Dis. 2007, 50:641-4. 10.1053\/j.ajkd.2007.05.027","journal-title":"Am J Kidney Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/240153-fibrillary-glomerulonephritis-leading-to-end-stage-renal-disease-in-the-absence-of-active-or-chronic-hepatitis-c-infection-current-insights","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T18:00:30Z","timestamp":1717696830000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/240153-fibrillary-glomerulonephritis-leading-to-end-stage-renal-disease-in-the-absence-of-active-or-chronic-hepatitis-c-infection-current-insights"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,6]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.61831","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,6]]}}}